NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer
Open Access
- 9 February 2023
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2023, 1-17
Abstract
Emerging evidence has revealed the significant roles of nicotinamide n-methyltransferase (NNMT) in cancer initiation, development, and progression; however, a pan-cancer analysis of NNMT has not been conducted. In this study, we first thoroughly investigated the expression and prognostic significance of NNMT and the relationship between NNMT and the tumor microenvironment using bioinformatic analysis. NNMT was significantly increased and associated with poor prognosis in many common cancers. NNMT expression correlated with the infiltration levels of cancer-associated fibroblasts and macrophages in pan-cancer. Function enrichment analysis discovered that NNMT related to cancer-promoting and immune pathways in various common cancers, such as colon adenocarcinoma, head and neck squamous cell carcinoma, ovarian serous cystadenocarcinoma, and stomach adenocarcinoma. NNMT expression was positively correlated with tumor-associated macrophages (TAMs), especially M2-like TAMs. The results suggest that NNMT might be a new biomarker for immune infiltration and poor prognosis in cancers, providing new direction on therapeutics of cancers.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming AbilityClinical Cancer Research, 2017
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Research, 2017
- Tumor Microenvironment and Differential Responses to TherapyCold Spring Harbor Perspectives in Medicine, 2017
- Tumor microenvironment and therapeutic responseCancer Letters, 2017
- Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathwayOncotarget, 2016
- Nicotinamide N-methyltransferase: a potential biomarker for worse prognosis in gastric carcinoma2016
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Nicotinamide N -methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cellsCarcinogenesis, 2010
- Oncomine 3.0: Genes, Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression ProfilesNeoplasia, 2007
- Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limmaBMC Genomics, 2006